An Open-Label Extension Study of Batoclimab in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Clinical trial NCT07188844 · TERMINATED
Trial details
- NCT number
- NCT07188844
- Sponsor
- Immunovant Sciences GmbH
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-28
- Primary completion
- 2026-07-16
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.